Skip to main content
PFSA
NASDAQ Industrial Applications And Services

Profusa Q3 Loss Narrows to $4.95M; Cash Falls to $0.34M With Going Concern Doubt

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.442
Mkt Cap
$267.69K
52W Low
$0.402
52W High
$1,539.754
52W Position info
9.9% above low
Off High info
100% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

PFSA is trading near its 52-week low of $0.402 (9.9% above the low) on light trading volume (0.1× avg).

Summary

Profusa's Q3 loss narrowed to $4.95 million on lower expenses, but cash fell to $0.34 million and management reiterated going-concern doubt. Heavy further dilution looms from the $28.3 million G3 option asset, a 14.7 million-share preferred overhang, and November debt conversions at $0.46.


Key Events · Earnings and Guidance · PFSA

  • Q3 Loss Narrows to $4.95M

    Net loss fell to $4.95 million from $26.09 million a year earlier, helped by a $7.35 million fair-value gain on convertible notes; the nine-month loss was $17.16 million versus $31.15 million.

  • Cash Drops to $0.34M

    Cash was $0.34 million at September 30 versus $1.78 million at December 31, 2025, with a working capital deficit of about $20.7 million and substantial doubt about going concern reiterated.

  • G3 Option Asset at $28.3M

    The G3 call option is carried as a $28.3 million non-current asset funded by 50,280 common shares and 52,903.566 Series A preferred shares; exercise still requires $30 million of financing and other conditions.

  • 14.7M-Share Preferred Overhang

    58,832.859 Series A preferred shares are outstanding and convertible into 14,708,215 common shares once stockholders approve, against 5,681,947 shares outstanding as of November 13, 2026.


Analysis · PFSA · Industrial Applications And Services

The headline improvement in Profusa's third quarter is largely accounting noise: the loss narrowed sharply to $4.95 million from $26.09 million a year earlier, but a $7.35 million fair-value gain on convertible notes and a $7.89 million loss on debt extinguishment offset each other, while operating expenses fell 78% to $4.85 million. Liquidity is the real story. Cash stood at just $0.34 million on September 30 against a $20.7 million working capital deficit, and management again says substantial doubt exists about continuing as a going concern. Support comes from Ascent's PIPE facility, with $8.4 million still available at investor discretion, and an $86.9 million equity line, both of which depend on the counterparty and on a share price that has collapsed. Largest item on the balance sheet is the $28.3 million G3 call option asset, funded entirely with stock; it converts into roughly 14.7 million common shares if holders approve, enormous dilution against 5.68 million shares currently outstanding. Subsequent events show that dilution already accelerating: NVAC converted its remaining note into 2.15 million shares at $0.46 on the filing date, and October amendments cut conversion floors to $0.338 and $0.20, so further conversions will issue even more shares at lower prices.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PFSA was trading at $0.44 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $267.7K. The 52-week trading range was $0.40 to $1,539.75. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PFSA - Latest Insights

PFSA
Nov 12, 2026, 7:30 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.7158
Real-time Price: $0.448 info
Change: -$0.2678 (-37%) info
Market Cap: $269.937K info
PFSA
Nov 10, 2026, 5:09 PM EST
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.5203
Real-time Price: $0.448 info
Change: -$0.0723 (-14%) info
Market Cap: $269.937K info
PFSA
Nov 06, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.530
Real-time Price: $0.448 info
Change: -$0.082 (-15%) info
Market Cap: $269.937K info
PFSA
Oct 15, 2026, 6:10 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.26
Real-time Price: $0.448 info
Change: -$0.812 (-64%) info
Market Cap: $269.937K info
PFSA
Oct 09, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.41
Real-time Price: $0.448 info
Change: -$0.962 (-68%) info
Market Cap: $269.937K info